ProfileGDS4718 / 207933_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 37% 36% 36% 36% 37% 45% 39% 37% 40% 44% 37% 35% 35% 38% 39% 38% 38% 42% 36% 37% 39% 41% 35% 39% 40% 39% 42% 46% 36% 40% 42% 42% 40% 42% 44% 39% 43% 41% 42% 38% 34% 33% 41% 40% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8551337
GSM549102patient 115, normal, homogenized [OPG study]4.839336
GSM549104patient 119, normal, homogenized [OPG study]4.8100436
GSM549108patient 138, normal, homogenized [OPG study]4.8568136
GSM549119patient 077, normal, homogenized [OPG study]4.8694337
GSM549133patient 032, cancer, homogenized [OPG study]5.1975145
GSM549139patient 042, cancer, homogenized [OPG study]4.9118839
GSM549099patient 107, normal, homogenized [OPG study]4.8925937
GSM549109patient 139, normal, homogenized [OPG study]5.0337940
GSM549110patient 046, normal, homogenized [OPG study]5.1980444
GSM549114patient 063, normal, homogenized [OPG study]4.8054837
GSM549122patient 082, normal, homogenized [OPG study]4.7711135
GSM549134patient 033, cancer, homogenized [OPG study]4.7420935
GSM549136patient 036, cancer, homogenized [OPG study]4.8211238
GSM549140patient 044, cancer, homogenized [OPG study]4.9058539
GSM549111patient 047, normal, homogenized [OPG study]4.8718538
GSM549113patient 057, normal, homogenized [OPG study]4.8581538
GSM549132patient 031, cancer, homogenized [OPG study]5.0865142
GSM549137patient 038, cancer, homogenized [OPG study]4.7979836
GSM549142patient 047, cancer, homogenized [OPG study]4.9930237
GSM549100patient 110, normal, homogenized [OPG study]4.9760639
GSM549107patient 135, normal, homogenized [OPG study]5.0323341
GSM549115patient 068, normal, homogenized [OPG study]4.682235
GSM549116patient 072, normal, homogenized [OPG study]4.8963339
GSM549120patient 078, normal, homogenized [OPG study]4.9690740
GSM549131patient 030, cancer, homogenized [OPG study]4.8987539
GSM549118patient 074, normal, homogenized [OPG study]5.0729242
GSM549129patient 027, cancer, homogenized [OPG study]5.2938746
GSM549123patient 088, normal, homogenized [OPG study]4.7931736
GSM549124patient 006, cancer, homogenized [OPG study]5.0067340
GSM549126patient 015, cancer, homogenized [OPG study]5.0865142
GSM549128patient 025, cancer, homogenized [OPG study]5.0543642
GSM549103patient 117, normal, homogenized [OPG study]5.0509540
GSM549117patient 073, normal, homogenized [OPG study]5.0483742
GSM549138patient 041, cancer, homogenized [OPG study]5.1745544
GSM549141patient 045, cancer, homogenized [OPG study]4.8906539
GSM549130patient 028, cancer, homogenized [OPG study]5.1646643
GSM549101patient 111, normal, homogenized [OPG study]5.0765841
GSM549105patient 128, normal, homogenized [OPG study]5.1161942
GSM549106patient 134, normal, homogenized [OPG study]4.8342138
GSM549112patient 048, normal, homogenized [OPG study]4.7126334
GSM549125patient 011, cancer, homogenized [OPG study]4.6777533
GSM549127patient 024, cancer, homogenized [OPG study]5.0478541
GSM549135patient 035, cancer, homogenized [OPG study]4.9213940